MFIMFI
BIIB icon

Mesirow Financial Investment Management - Fixed Income’s Biogen BIIB Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,425
Closed -$344K – 240
2016
Q2 		$344K Buy
+1,425
New +$376K 0.02% 170
2014
Q3 		– Sell
-2,586
Closed -$815K – 172
2014
Q2 		$815K Buy
+2,586
New +$778K 0.2% 134

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's BIIB Position: Q3 2016 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Biogen (BIIB) in Q3 2016, closing a stake of 1,425 shares — an estimated $344K sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in BIIB in Q2 2014 and held it in 2 quarters. The position peaked at $815K in Q2 2014. 1,013 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

  • Mesirow Financial Investment Management - Fixed Income reported no remaining Biogen position as of Q3 2016 after selling out during the quarter.
  • Mesirow Financial Investment Management - Fixed Income sold 1,425 Biogen shares in Q3 2016, an estimated $344K.
  • Mesirow Financial Investment Management - Fixed Income first reported a position in Biogen in Q2 2014 and held it in 2 quarters.
  • Mesirow Financial Investment Management - Fixed Income's Biogen position peaked at $815K in Q2 2014.
  • 1,013 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q3 2016, filed 28 Oct 2016.